Generation Bio Co. — Investor Relations & Filings
Generation Bio Co. is a biotechnology company developing therapeutics for T cell-driven autoimmune diseases. The company's platform utilizes proprietary cell-targeted lipid nanoparticles (ctLNPs) to selectively deliver small interfering RNA (siRNA) to T cells. This approach is designed to potently silence specific genes and modulate the function of autoreactive T cells responsible for tissue and organ damage. The technology aims to provide redosable treatments with genetic precision and tunable pharmacology, while sparing the broader immune system from off-target effects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-10 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Fusen Pharmaceutical Company Limited
Integrates herbal medicine cultivation, R&D, production, an…
|
1652 | HK | Manufacturing |
|
Fuso Pharmaceutical Industries,Ltd.
Develops and manufactures pharmaceuticals, focusing on infu…
|
4538 | JP | Manufacturing |
|
FUTURA MEDICAL PLC
Pharmaceutical company developing topical gel formulations …
|
FUM | GB | Manufacturing |
|
FutureChem Co., Ltd.
Develops radiopharmaceuticals and synthesis equipment for d…
|
220100 | KR | Manufacturing |
|
Future Medicine Co., Ltd.
Develops nucleoside-based synthetic drugs for antiviral and…
|
341170 | KR | Manufacturing |
|
G2GBIO, Inc.
Develops sustained-release drugs using a long-acting inject…
|
456160 | KR | Manufacturing |
|
Gabather AB
Develops therapeutics for CNS disorders by targeting the GA…
|
GABA | SE | Manufacturing |
|
GABY Inc.
Produces, markets, and retails cannabis and hemp-derived we…
|
GABY | CA | Manufacturing |
|
Gain Therapeutics, Inc.
Develops allosteric small molecule therapies using an AI dr…
|
GANX | US | Manufacturing |
|
Galapagos NV
A biotechnology company focused on a rapid, decentralized c…
|
GLPG | BE | Manufacturing |
Generation Bio Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34688/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34688 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34688 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34688 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34688}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Generation Bio Co. (id: 34688)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.